review on glp-1 agonists and psychiatric effects The expanding role of receptor agonists: a narrative of current evidence future directions Glucagon-like peptide-1 (GLP-1) receptor agonists

Common reasons include: Pernicious anemia , an autoimmune condition affecting intrinsic factor production Gastrointestinal disorders, such as Crohns disease or celiac disease Prolonged use of certain medications, like proton pump inhibitors Knowing these causes helps spot at-risk people

Hanahan, D

Meyerstein D

Ongoing research continues to evaluate the efficacy and safety of these and other emerging therapies [21, 22]

Exploring the relationships among nutrients, the gut microbiota, and depression, and promoting optimized dietary patterns, has therefore become a primary strategy for the early intervention of depression in at-risk individuals

Many patients experience a reduced appetite after their first injection, although it may take longer depending on individual factors